Sanitas S.A. De Hospitales

Clinical research at this site focuses on immune system diseases, with a strong emphasis on Sjögren’s disease and related autoimmune conditions. The trials are designed to better understand how these disorders affect both systemic health and daily symptoms, while also assessing new treatment options for people with moderate to severe disease.

• Studies in Primary Sjögren’s Disease and Sjögren’s Syndrome
• Research aimed at easing systemic disease activity and symptom burden
• Evaluation of new therapies for autoimmune inflammation and patient-reported outcomes

The work at the Barcelona site reflects a focused effort to improve both treatment effectiveness and the overall understanding of this chronic autoimmune condition.

This research area centers on Sjögren’s disease, exploring whether emerging therapies can reduce disease activity and improve symptoms in adults with moderate to severe illness. The studies are also looking at how well patients feel in everyday life, making symptom relief an important part of the research goal.

• Testing treatments for moderate to severe Sjögren’s disease
• Measuring changes in systemic manifestations
• Assessing improvement in patient-reported symptoms

These trials help determine whether new approaches can offer meaningful benefits for people living with persistent autoimmune symptoms.

The clinical trials at Sanitas S.A. De Hospitales are also part of a broader effort to evaluate the effectiveness and safety of investigational therapies for autoimmune disease. Rather than focusing on one symptom alone, these studies examine how treatment may influence overall disease control and day-to-day well-being.

• Comparing new therapies with placebo in Sjögren’s syndrome
• Studying systemic disease activity as a key outcome
• Supporting development of better options for autoimmune disease management

Together, the trials contribute to ongoing research into more effective care for people affected by this rare and often challenging condition.